Neurotransmitter Degradation Absence: Synaptic Consequences and Clinical Examples

If degradative enzymes (e.g., acetylcholinesterase, MAO, COMT) are absent at a synapse, neurotransmitter accumulates, causing profound signaling disruption. Enzymatic clearance is essential for temporal precision, dynamic range, and neuroprotection.

Consequences

  1. Prolonged receptor activation: Persistent binding → sustained postsynaptic depolarization (excitatory) or hyperpolarization (inhibitory).
  2. Receptor desensitization/downregulation: Chronic overstimulation → internalization, reduced sensitivity → paradoxical signal loss.
  3. Excitotoxicity (glutamate): Excessive NMDA/AMPA activation → Ca²⁺ influx → mitochondrial failure, ROS, apoptosis.
  4. Autonomic crisis (ACh): Unchecked muscarinic/nicotinic stimulation → bronchospasm, bradycardia, salivation, fasciculations, paralysis.
  5. Monoamine toxicity: Serotonin syndrome (5-HT), hypertensive crisis (NE), psychosis (DA).
  6. Synaptic plasticity disruption: Impaired LTP/LTD → learning/memory deficits.
  7. Network instability: Seizures, abnormal oscillations, behavioral stereotypies.

Clinical Examples

  • Organophosphate poisoning (AChE inhibition) → cholinergic crisis.
  • MAOI + tyramine/SSRI → serotonin syndrome.
  • Genetic: Succinic semialdehyde dehydrogenase deficiency (GABA accumulation).

Brain & Nervous System - Related Articles